The next-generation weight loss drug that’s ‘as effective as Mounjaro – WITHOUT Ozempic side effect’

A NEW weight loss drug may offer a tempting alternative to popular GLP-1 drugs like Ozempic and Wegovy. The once-weekly ...

Diabetes meds for weight loss, explained by the pros

This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some ...

Novo Nordisk, Emcure Pharma to launch weight-loss drug under new brand

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk ...
GlobalData on MSN

Lilly to advance alternative obesity candidate to Phase III

Eli Lilly is advancing its obesity treatment candidate, which is an alternative to glucagon-like peptide-1 receptor agonists ...

Novo Nordisk bets on Emcure to win India’s weight-loss drug war

Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...
Hespress on MSN

Semaglutide officially enters Moroccan market amid global rush for GLP-1 drugs

Semaglutide, the diabetes drug at the center of a global boom in weight-loss treatments, has entered the Moroccan market through a partnership between Danish pharmaceutical company Novo Nordisk and ...

Semaglutide showdown: Pills or shots—Which is right for you?

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...
The Financial Express

Novo Nordisk partners Emcure Pharma to commercialise weight loss drug Poviztra in India

Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about this latest ...